Implications of IL-6 Targeting Therapy for Sepsis

Sujin Kang^1,2*, Toshio Tanaka^1,2, Kazuya Masuda³ and Tadamitsu Kishimoto³

¹Department of Clinical Application of Biologics, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan

²Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan

³Laboratory of Immune Regulation, WPI-Immunology Frontier Research Center, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan

^*Corresponding Author: Sujin Kang, Department of Clinical Application of Biologics, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan, Tel: +81-6-6879-3833 Email:

Commentary